Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer

L. G.M. Jorgensen; F. R. Hirsch; K. Osterlind

doi:10.1038/bjc.1991.31

Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer

L. G.M. Jorgensen, F. R. Hirsch, K. Osterlind

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Abstract

An analysis has been made of the relationship between neuron specific enolase (NSE) in serum and immunohistochemically identified occurrence of NSE in the primary tumour in 56 patients with small cell lung cancer (SCLC). Patients were referred to the Finsen Institute for treatment during a period of 18 months. Forty-six tumours (82%) were NSE positive. To compare this staining with the occurrence of NSE in serum, a histological staining index (HSI) was established by semiquantitative gradation of the staining. No significant differences were found between distribution of serum NSE values in different HSI categories, and a high ranking in HSI was not associated with a high level of serum NSE. Both univariate and multivariate analysis selected serum NSE and not HSI as the most influential prognostic factor in SCLC.

Original language	English
Pages (from-to)	151-153
Number of pages	3
Journal	British Journal of Cancer
Volume	63
Issue number	1
DOIs	https://doi.org/10.1038/bjc.1991.31
State	Published - Jan 1991
Externally published	Yes

Access to Document

10.1038/bjc.1991.31

Cite this

@article{5489ffd9349f44bb9e18b50625a299bd,

title = "Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer",

abstract = "An analysis has been made of the relationship between neuron specific enolase (NSE) in serum and immunohistochemically identified occurrence of NSE in the primary tumour in 56 patients with small cell lung cancer (SCLC). Patients were referred to the Finsen Institute for treatment during a period of 18 months. Forty-six tumours (82%) were NSE positive. To compare this staining with the occurrence of NSE in serum, a histological staining index (HSI) was established by semiquantitative gradation of the staining. No significant differences were found between distribution of serum NSE values in different HSI categories, and a high ranking in HSI was not associated with a high level of serum NSE. Both univariate and multivariate analysis selected serum NSE and not HSI as the most influential prognostic factor in SCLC.",

author = "Jorgensen, {L. G.M.} and Hirsch, {F. R.} and K. Osterlind",

year = "1991",

month = jan,

doi = "10.1038/bjc.1991.31",

language = "English",

volume = "63",

pages = "151--153",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer

AU - Jorgensen, L. G.M.

AU - Hirsch, F. R.

AU - Osterlind, K.

PY - 1991/1

Y1 - 1991/1

N2 - An analysis has been made of the relationship between neuron specific enolase (NSE) in serum and immunohistochemically identified occurrence of NSE in the primary tumour in 56 patients with small cell lung cancer (SCLC). Patients were referred to the Finsen Institute for treatment during a period of 18 months. Forty-six tumours (82%) were NSE positive. To compare this staining with the occurrence of NSE in serum, a histological staining index (HSI) was established by semiquantitative gradation of the staining. No significant differences were found between distribution of serum NSE values in different HSI categories, and a high ranking in HSI was not associated with a high level of serum NSE. Both univariate and multivariate analysis selected serum NSE and not HSI as the most influential prognostic factor in SCLC.

AB - An analysis has been made of the relationship between neuron specific enolase (NSE) in serum and immunohistochemically identified occurrence of NSE in the primary tumour in 56 patients with small cell lung cancer (SCLC). Patients were referred to the Finsen Institute for treatment during a period of 18 months. Forty-six tumours (82%) were NSE positive. To compare this staining with the occurrence of NSE in serum, a histological staining index (HSI) was established by semiquantitative gradation of the staining. No significant differences were found between distribution of serum NSE values in different HSI categories, and a high ranking in HSI was not associated with a high level of serum NSE. Both univariate and multivariate analysis selected serum NSE and not HSI as the most influential prognostic factor in SCLC.

UR - http://www.scopus.com/inward/record.url?scp=0026019680&partnerID=8YFLogxK

U2 - 10.1038/bjc.1991.31

DO - 10.1038/bjc.1991.31

M3 - Article

C2 - 1703432

AN - SCOPUS:0026019680

SN - 0007-0920

VL - 63

SP - 151

EP - 153

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 1

ER -

Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer

Abstract

Access to Document

Fingerprint

Cite this